E02.319.267.530.475.500

6 trials

Sponsors

Hospital de Olhos de Sergipe, Universidade Federal de Pernambuco, Universidade Federal de São Paulo

Conditions

Diabetic retinopathyIridocyclitisMacular Edema

Phase 2

Treatment of Diabetic macular edema with intravitreal injection of antiangiogenic agents with or without Dexamethasone

Active, not recruitingRBR-7468j4q

Universidade Federal de PernambucoMacular Edema

Start: 2023-07-01Updated: 2025-10-27

Treatment of Diabetic Macular Edema with Intraocular Injection of Dexamethasone

RecruitingRBR-59phz5c

Universidade Federal de PernambucoMacular Edema

Start: 2023-05-23Updated: 2025-10-27

Intravitreal injection of dexamethasone disodium phosphate as a predictor of response to intravitreal dexamethasone implant in diabetic macular edema refractory to anti-VEGF therapy

Active, not recruitingRBR-2bgcvwj

Universidade Federal de PernambucoMacular Edema

Start: 2024-10-01Updated: 2025-10-27

Short-term Intraocular Pressure changes after intraocular injection of 0.05 mL of Aflibercept 40 mg/mL and 0.02 mL of Aflibercept 114.3 mg/mL

RecruitingRBR-2vmd7y7

Universidade Federal de PernambucoMacular Edema

Start: 2025-07-01Updated: 2025-10-27

Unknown Phase

Assessment of eye inflammation after intravitreal injection injection

RecruitingRBR-95ddhp

Universidade Federal de São PauloIridocyclitis

Start: 2019-07-01Updated: 2025-10-27

Clinical study to detect the presence of silicone oil released by syringes used for intraocular injection

RecruitingRBR-10tn82jt

Hospital de Olhos de SergipeDiabetic retinopathy

Start: 2021-11-01Updated: 2025-10-27

Related Papers

Intravitreal aflibercept alone versus combination with dexamethasone phosphate for diabetic macular edema: A randomized phase-2 clinical trial.

2025-07-21

Ocular inflammation after agitation of siliconized and silicone oil-free syringes: a randomized, double-blind, controlled clinical trial.

2022-06-177 citations